[ET Net News Agency, 31 August 2021] Sino Biopharmaceutical Limited (01177) said its
profit attributable to owners of the parent was HK$8.48 billion for the six months ended
30 June 2021, a year-on-year increase of 583.6%. A quarterly dividend of HK2 cents will be
distributed.
Revenue was HK$14.35 billion, a year-on-year increase of 13.5%. (RC)